Margareta Wikén

A Randomized, Phase II Study Evaluating the Efficacy and Safety of Anakinra in the Treatment of Gout Flares

Kenneth G. Saag, Puja Khanna, Robert T. Keenan et al. · Arthritis & Rheumatology · 2021 · 82 citations · Full text

Induction of CD43 Expression during Activation and Terminal Differentiation of Human B Cells

Margareta Wikén, P Björck, Bertil Axelsson et al. · Scandinavian Journal of Immunology · 1988 · 48 citations

Consistent manufacturing and quality control of a highly complex recombinant polyclonal antibody product for human therapeutic use

Torben P. Frandsen, Henrik Næsted, Søren K. Rasmussen et al. · Biotechnology and Bioengineering · 2011 · 42 citations

Immunocytochemical Technique, Engineering, Immunology +18

Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study

Margareta Wikén, B. Hallén, Torbjörn Kullenberg et al. · Clinical Rheumatology · 2018 · 24 citations · Full text

Enhancement of Human B‐Cell Proliferation by a Monoclonal Antibody to CD43

Margareta Wikén, P Björck, Bertil Axelsson et al. · Scandinavian Journal of Immunology · 1989 · 14 citations